this post was submitted on 23 Feb 2024
50 points (98.1% liked)

Technology

34894 readers
857 users here now

This is the official technology community of Lemmy.ml for all news related to creation and use of technology, and to facilitate civil, meaningful discussion around it.


Ask in DM before posting product reviews or ads. All such posts otherwise are subject to removal.


Rules:

1: All Lemmy rules apply

2: Do not post low effort posts

3: NEVER post naziped*gore stuff

4: Always post article URLs or their archived version URLs as sources, NOT screenshots. Help the blind users.

5: personal rants of Big Tech CEOs like Elon Musk are unwelcome (does not include posts about their companies affecting wide range of people)

6: no advertisement posts unless verified as legitimate and non-exploitative/non-consumerist

7: crypto related posts, unless essential, are disallowed

founded 5 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
[–] BaumGeist@lemmy.ml 4 points 8 months ago

Here's the journal article itself

This whole thing stinks of advertising. They use a sample size of 24 people. The results are underwhelming: "Each disease cohort concordantly demonstrated increases in the NAD+/NADH ratio but did not reach significance individually" ("when we massaged the numbers, the result we wanted popped out"). Looking at the graphs, it looks like the upper half (highest baselines) of the patients worsened over the 12 week study.

My favorite lines?

"The objective of the Phase 2 REPAIR-MS and REPAIR-PD clinical trials was to investigate the effects of CNM-Au8" and "CNM-Au8® is a suspension of faceted, clean-surfaced gold nanocrystals" and course:

"Clene Nanomedicine, Inc., funded this study."